http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Romero-Garay Martha Guillermina,Martínez-Montaño Emmanuel,Hernández-Mendoza Adrián,Vallejo-Cordoba Belinda,González-Córdova Aarón Fernando,Montalvo-González Efigenia,García-Magaña María de Lourdes 한국응용생명화학회 2020 Applied Biological Chemistry (Appl Biol Chem) Vol.63 No.4
In the present study, we evaluated new sources of plant proteases from fruits of Bromelia karatas (BK) and Bromelia pinguin (BP) to obtain antioxidant hydrolyzates/bioactive peptides (BPs) derived from chicken by-products (CH) and fish by-products (FH). The profile of the peptides was identified by reverse-phase high-resolution liquid chromatography (RP-HPLC) and the size weight distribution by molecular exclusion chromatography (SEC). The hydrolysates obtained with BK in both sources of by-products showed greater antioxidant capacity compared to those obtained with BP, presenting similar or higher values when compared to a commercial plant enzyme. The use of new sources of plant proteases allowed to obtain hydrolysates of hydrophilic character with a high percentage (> 50%) of peptides with molecular weights < 17.5 kDa from chicken and fish by-products. Therefore, based on the results obtained in antioxidant capacity it is possible to consider the hydrolysates as potential ingredients, food additives, and pharmaceutical products.
Luisa Islas,Guillermina Burillo,Alejandra Ortega 한국고분자학회 2018 Macromolecular Research Vol.26 No.8
Chitosan (CS) was modified with 2-hydroxyethyl methacrylate (HEMA) by gamma radiation to improve its water absorption ability and use it as a drug delivery system. For this, HEMA was grafted by direct method onto dissolved CS (homogeneous) or powder CS (heterogeneous) using doses less than 20 kGy. The grafting percentage was easily controlled changing the homogeneity of system. Low and medium grafting percentages (20-70%) were obtained with the heterogeneous method, while the homogeneous method yielded higher grafting percentages (~340%). CS-g-HEMA was confirmed using infrared spectroscopy (ATR-FTIR), thermogravimetric analyses (TGA) and X-ray diffraction (XRD). In addition, the swelling behaviour, critical pH, and drug absorption, using diclofenac as a model, were also evaluated. Results show that the presence of HEMA had a positive effect on swelling and the drug uptake when low grafting percentages were used; CS-g-HEMA (17%) swelled in water (261%) and loaded better amounts of diclofenac (1.5 mg g-1) than CS (0.97 mg g-1).
Thurman, Joshua M.,Kraus, Damian M.,Girardi, Guillermina,Hourcade, Dennis,Kang, Hee J.,Royer, Pamela A.,Mitchell, Lynne M.,Giclas, Patricia C.,Salmon, Jane,Gilkeson, Gary,Holers, V. Michael Elsevier 2005 Molecular immunology Vol.42 No.1
<P><B>Abstract</B></P><P>Studies in gene-targeted mice have demonstrated that factor B of the alternative complement pathway plays an important role in several disease models, but an exogenous inhibitor of factor B has not previously been available. We have developed an inhibitory monoclonal antibody directed against a critical epitope on mouse factor B and have tested it in a model of antiphospholipid (aPL) antibody (Ab)-induced fetal loss. Gene-targeted factor B-deficient mice (fB<SUP>−/−</SUP>) were injected with a fusion protein comprised of the second and third short consensus repeat (SCR) domains of mouse factor B linked to a mouse IgG<SUB>1</SUB> Fc domain. Hybridomas were made from splenocytes of the immunized mouse. One mAb, designated 1379, produced an IgG<SUB>1</SUB> antibody that inhibited alternative pathway activation in vitro and in vivo by preventing formation of the C3bBb complex. Strikingly, this mAb inhibited alternative pathway activation in serum from mice, rats, humans, monkeys, pigs and horses. Fab fragments made from this mAb also inhibited alternative pathway activation. Epitope mapping demonstrated that this antibody binds to factor B within the third SCR domain. When mAb 1379 was administered to mice that also received human IgG containing antiphospholipid antibodies, it provided significant protection from antiphospholipid antibody-induced complement activation and fetal loss. Thus, this mAb to factor B has broad species reactivity and effectively inhibits alternative pathway activation. The mAb protects mice in an in vivo model of antiphospholipid antibody syndrome, demonstrating the therapeutic potential for the inhibition of factor B in this disease.</P>
Ivan Cherrez-Ojeda,Miguel Felix,Valeria L. Mata,Emanuel Vanegas,Antonio W. D. Gavilanes,Peter Chedraui,Daniel Simancas-Racines,Juan Carlos Calderon,Fabian Ortiz,Guillermina Blum,Angela Plua,Gino Gonza 대한의료정보학회 2018 Healthcare Informatics Research Vol.24 No.4
Objectives: The aim of the present study was to assess the frequency of use, and preferences regarding information and communication technologies (ICTs) among Ecuadorian patients with chronic kidney disease (CKD) undergoing hemodialysis. Methods: We conducted an anonymous cross-sectional survey-based study from January 2016 to April 2017, involving 393 patients with end-stage renal disease from 9 hemodialysis centers, in which they rated their use and preferences of various ICTs through a modified version of the Michigan Questionnaire. The questionnaire collected information regarding demographics, patients’ interest in obtaining health-related information through ICTs, and interest in using ICTs as a potential way to communicate with their healthcare providers. A chi-square test for association and adjusted regression analyses were performed. Results: Among all patients who participated, 64.3% reported owning a cellphone, with less than a third reporting active Internet connection. The most used ICT for obtaining information about CKD and/or hemodialysis was web-based Internet, followed by YouTube. SMS was rated the highest to receive and seek health-related information, followed by Facebook. Younger age and higher levels of education were associated with a higher overall usage of ICTs. Finally, more than half of the patients reported interest in using WhatsApp for communicating with their healthcare providers. Conclusions: Understanding the preferences of ICTs among patients with CKD undergoing hemodialysis could help to improve their outcomes through the potential uses and benefits of ICTs. Further research is needed to assess their role in improving the care of patients with chronic diseases.